UBS(Lux)E.F.-Biotech(USD)P a.USD
MVD-Fonds Rating | EDA |
---|---|
![]() ![]() ![]() ![]() ![]() ![]() | 74 |
ISIN: LU0069152568 | WKN: 986327
KAG: UBS Fund M. (LU)
NAV: 758,68 USD am 14.04.2021

Kennzahlen UBS(Lux)E.F.-Biotech(USD)P a.USD
1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
Performance | -3,10% | -0,34% | +18,77% | +34,94% | +57,22% | +260,59% | +658,68% |
Volatilität | +23,36% | +22,90% | +24,27% | +25,84% | +24,24% | +25,41% | +27,86% |
Sharpe Ratio | -1,34 | -0,01 | +0,80 | +0,43 | +0,41 | +0,56 | +0,33 |
Bester Monat | - | +10,70% | +14,55% | +14,95% | +14,95% | +15,66% | +41,13% |
Schl. Monat | - | -4,94% | -4,94% | -13,55% | -13,55% | -21,18% | -28,27% |
Max. Verlust | -5,67% | -14,33% | -15,52% | -25,18% | -25,72% | -40,97% | -75,23% |
Monatsperformance UBS(Lux)E.F.-Biotech(USD)P a.USD
2011 | 2010 | 2009 | 2008 | 2007 | |
Januar | -0,88% | +3,91% | -1,06% | -3,27% | +1,70% |
Februar | +1,46% | +1,85% | -9,83% | -4,34% | -1,89% |
März | +7,18% | +7,90% | +5,49% | +0,96% | -0,67% |
April | +6,85% | -0,85% | -0,09% | +0,89% | +8,05% |
Mai | +1,41% | -11,79% | +1,98% | +4,52% | -0,01% |
Juni | -4,56% | -4,93% | +9,13% | -1,16% | -5,25% |
Juli | -2,97% | +7,69% | +11,32% | +17,71% | -2,25% |
August | -10,14% | -1,88% | -0,45% | -5,19% | +5,69% |
September | -3,14% | +11,30% | +1,53% | -6,71% | +4,85% |
Oktober | +7,25% | -0,53% | -11,08% | -11,52% | +2,15% |
November | -1,54% | -2,62% | +7,86% | -9,04% | -1,93% |
Dezember | +2,44% | +5,68% | +3,96% | +10,57% | -4,83% |
Gesamt | +1,84% | +14,31% | +17,39% | -9,79% | +4,78% |